North American Treatment Guidelines

The first evidence-based clinical management guidelines for Hidradenitis Suppurativa patients in North America

HSF Danby Research Grants

Basic, translational, and treatment-centered research directed by the unmet needs of patients

Hidradenitis Suppurativa is a disease which has a tremendous impact on the quality of life of a patient. In fact, it is considered to be one of the most severe conditions in dermatology. Thus it is our duty to drive support for research that will someday lead to a cure. Research is hope for our HS patients so please join our community in advancing our movement toward a cure.
Iltefat Hamzavi, MD
President, Hidradenitis Suppurativa Foundation
Back to Top